{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:11:01Z","timestamp":1760004661581,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018987","name":"Ministerul Cercet\u0103rii, Inov\u0103rii \u015fi Digitaliz\u0103rii","doi-asserted-by":"publisher","award":["PN-III-P1-1.1-PD-2021-0117"],"award-info":[{"award-number":["PN-III-P1-1.1-PD-2021-0117"]}],"id":[{"id":"10.13039\/100018987","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006595","name":"Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008604","name":"Canadian Nuclear Safety Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008604","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jpba.2023.115495","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T11:01:30Z","timestamp":1686394890000},"page":"115495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Simultaneous determination of enantiomeric and organic impurities of vildagliptin on a cellulose tris(3-chloro-4-methylphenylcarbamate) column under revered-phase conditions"],"prefix":"10.1016","volume":"234","author":[{"given":"Lajos-Attila","family":"Papp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2564-9271","authenticated-orcid":false,"given":"Gabriel","family":"Hancu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n-Istv\u00e1n","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2023.115495_bib1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41581-020-0278-5","article-title":"Genetics of diabetes mellitus and diabetes complications","volume":"16","author":"Cole","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jpba.2023.115495_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bbapap.2005.05.010","article-title":"Type 2 diabetes - Therapy with dipeptidyl peptidase IV inhibitors","author":"Demuth","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jpba.2023.115495_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.115263","article-title":"Anti-diabetic drugs recent approaches and advancements","volume":"28","author":"Dowarah","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jpba.2023.115495_bib4","first-page":"429","article-title":"Validated chiral ultra fast liquid chromatographic method for quantitative analysis of enantiomeric vildagliptin","volume":"12","author":"Srinivas","year":"2021","journal-title":"Am. J. Anal. Chem."},{"key":"10.1016\/j.jpba.2023.115495_bib5","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/elps.201500442","article-title":"Development and validation of a cyclodextrin-modified capillary electrophoresis method for the enantiomeric separation of vildagliptin enantiomers","volume":"37","author":"Kazsoki","year":"2016","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jpba.2023.115495_bib6","series-title":"Encycl. Anal. Chem.","first-page":"1","article-title":"Chiral separations by high\u2010performance liquid chromatography","author":"Ward","year":"2019"},{"key":"10.1016\/j.jpba.2023.115495_sbref7","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2020.115807","article-title":"Chiral capillary electrophoresis","volume":"124","author":"Bernardo-Bermejo","year":"2020","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jpba.2023.115495_sbref8","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2022.116550","article-title":"Current state and future perspectives of supercritical fluid chromatography","volume":"149","author":"Si-Hung","year":"2022","journal-title":"TrAC - Trends Anal. Chem."},{"key":"10.1016\/j.jpba.2023.115495_bib8","first-page":"93","article-title":"Polysaccharide-based chiral stationary phases for enantioseparations by high-performance liquid chromatography: an overview","volume":"2019","author":"Chankvetadze","year":"1985","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jpba.2023.115495_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/jssc.202100593","article-title":"Recent progress in the development of chiral stationary phases for high-performance liquid chromatography","volume":"45","author":"Zhang","year":"2022","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2023.115495_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jpba.2009.03.021","article-title":"Development and validation of an enantioselective and chemoselective HPLC method using a Chiralpak IA column to simultaneously quantify (R)-(+)- and (S)-(-)-lansoprazole enantiomers and related impurities","volume":"50","author":"Cirilli","year":"2009","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115495_bib11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jpha.2015.11.001","article-title":"Comparison of reversed-phase enantioselective HPLC methods for determining the enantiomeric purity of (S)-omeprazole in the presence of its related substances","volume":"6","author":"Gallinella","year":"2016","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jpba.2023.115495_sbref13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jpba.2018.06.012","article-title":"Simultaneous determination of dextromepromazine and related substances 2-methoxyphenothiazine and levomepromazine sulfoxide in levomepromazine on a cellulose tris(4-methylbenzoate) chiral column","volume":"158","author":"Niedermeier","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115495_sbref14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.112851","article-title":"Simultaneous determination of chiral and achiral impurities of ivabradine on a cellulose tris(3-chloro-4-methylphenylcarbamate) chiral column using polar organic mode","volume":"177","author":"Ferencz","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115495_bib13","doi-asserted-by":"crossref","first-page":"9022","DOI":"10.3390\/molecules27249022","article-title":"Simultaneous determination of escitalopram impurities including the R-enantiomer on a Cellulose tris(3,5-Dimethylphenylcarbamate)-Based chiral column in reversed-phase mode","volume":"27","author":"Szab\u00f3","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2023.115495_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115239","article-title":"Chemo- and enantio-selective reversed-phase HPLC analysis of rosuvastatin using a cellulose-based chiral stationary phase in gradient elution mode","volume":"225","author":"Mammone","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115495_bib15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11094-022-02606-1","article-title":"Physicochemical properties and methods of analysis of Vildagliptin (Review)","volume":"56","author":"Polyakova","year":"2022","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.jpba.2023.115495_bib16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jpba.2015.11.044","article-title":"Identification, isolation and characterization of potential process-related impurity and its degradation product in vildagliptin","volume":"119","author":"Kumar","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115495_bib17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/10826076.2020.1779084","article-title":"New forced degradation products of vildagliptin: Identification and structural elucidation using LC-MS","volume":"43","author":"Arar","year":"2020","journal-title":"Propos. Form. Mech., J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jpba.2023.115495_bib18","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.3390\/molecules26185632","article-title":"Comprehensive Insight into Chemical Stability of Important Antidiabetic Drug Vildagliptin Using Chromatography (LC-UV and UHPLC-DAD-MS) and Spectroscopy (Mid-IR and NIR with PCA)","volume":"26","author":"Gumieniczek","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2023.115495_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jpba.2009.03.021","article-title":"Development and validation of an enantioselective and chemoselective HPLC method using a Chiralpak IA column to simultaneously quantify (R)-(+)- and (S)-(-)-lansoprazole enantiomers and related impurities","volume":"50","author":"Cirilli","year":"2009","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115495_bib20","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/jssc.201200443","article-title":"HPLC separation of dihydropyridine derivatives enantiomers with emphasis on elution order using polysaccharide-based chiral columns","volume":"35","author":"Jibuti","year":"2012","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2023.115495_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.chroma.2013.07.021","article-title":"Retention behavior of proton pump inhibitors using immobilized polysaccharide-derived chiral stationary phases with organic-aqueous mobile phases","volume":"1304","author":"Cirilli","year":"2013","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.jpba.2023.115495_bib22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.chroma.2016.12.064","article-title":"Separation of enantiomers of chiral weak acids with polysaccharide-based chiral columns and aqueous-organic mobile phases in high-performance liquid chromatography: Typical reversed-phase behavior?","volume":"1483","author":"Matarashvili","year":"2017","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.jpba.2023.115495_bib23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/chromsci\/bmx094","article-title":"Development and validation of stereo selective method for the separation of razoxane enantiomers in hydrophilic interaction chromatography","volume":"56","author":"Thirupathi","year":"2018","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jpba.2023.115495_bib24","doi-asserted-by":"crossref","unstructured":"R. Cirilli, 2019. HPLC enantioseparations with polysaccharide-based chiral stationary phases in HILIC conditions, in: Methods Mol. Biol., Methods Mol Biol, 2019: pp. 127\u2013146.","DOI":"10.1007\/978-1-4939-9438-0_7"},{"key":"10.1016\/j.jpba.2023.115495_bib25","unstructured":"International Conference on Harmonization (ICH) Harmonised Tripartite Guideline Validation of Analytical Procedures: Text and Methodology Q2(R1), Geneva (2005)."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523002649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523002649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:29:55Z","timestamp":1760002195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708523002649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":27,"alternative-id":["S0731708523002649"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115495","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous determination of enantiomeric and organic impurities of vildagliptin on a cellulose tris(3-chloro-4-methylphenylcarbamate) column under revered-phase conditions","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115495","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115495"}}